Preeti Biotech Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 19 Year, 12 Days
- Last Filing with ROC 31 Mar 2022
- Revenue Growth 2.99%
- Profit Growth -10.71%
- Ebitda -10.66%
- Net Worth 18.58%
- Total Assets 20.00%
About Preeti Biotech
Preeti Biotech Pvt Ltd (PBPL) is a Private Limited Indian Non-Government Company incorporated in India on 20 January 2006 and has a history of 19 years. Its registered office is in Hyderabad, Telangana, India.
The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Nandyala Aruna and Sailaja Sanapalli serve as directors at the Company.
Company Details
-
Location
Hyderabad, Telangana, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U01119TG2006PTC048850
-
Company No.
048850
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
20 Jan 2006
-
Date of AGM
28 Sep 2022
-
Date of Balance Sheet
31 Mar 2022
-
Listing Status
Unlisted
-
ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at Preeti Biotech?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Nandyala Aruna
|
Director | 11-Jun-2019 | Current |
|
Sailaja Sanapalli
|
Director | 11-Jun-2019 | Current |
Financial Performance of Preeti Biotech.
Preeti Biotech Pvt Ltd, for the financial year ended 2020, experienced modest growth in revenue, with a 2.99% increase. The company also saw a substantial fall in profitability, with a 10.71% decrease in profit. The company's net worth Soared by an impressive increase of 18.58%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Preeti Biotech?
In 2018, Preeti Biotech had a promoter holding of 60.00% and a public holding of 40.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Preeti Developers Private LimitedNandyala Aruna is a mutual person
-
Preeti Affordabale Homes India LlpNandyala Aruna is a mutual person
-
R.R.C.O.R.P. Constructions Private Limited
Nandyala Aruna is a mutual person
-
Sreshta Eye Care Solutions Private Limited
Nandyala Aruna is a mutual person
-
Netra Diagnostics Private Limited
Nandyala Aruna is a mutual person
-
Mr Mansion Private Limited
Sailaja Sanapalli is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Preeti Biotech?
Unlock and access historical data on people associated with Preeti Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Preeti Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Preeti Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
